ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
EMA grants marketing authorisation for Prevymis against cytomegalovirus
November 13, 2017The EMA has recommended granting a marketing authorisation Prevymis, an antiviral medicine that prevents CMV reactivation and disease… -
MSD’s investigational cytomegalovirus treatment shows significant promise in Phase 3 trial
February 28, 2017MSD has lifted the curtain on strong Phase 3 results in the development of its investigational antiviral drug letermovir, showing the treatment hit its primary endpoint of an improvement in clinically significant cytomegalovirus (CMV) infection following
Pharma Sources Insight January 2025
